Pulmatrix, Inc. SEC filings PULM

Pulmatrix, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 24, 2013. Its latest annual report, Form ARS, was filed on Oct 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Pulmatrix, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Oct 5, 2026 Dec 31, 2025
10-K/A Amended annual report Jun 16, 2026 Dec 31, 2025
10-K Annual report Feb 26, 2026 Dec 31, 2025
10-K Annual report Mar 21, 2025 Dec 31, 2024
ARS Annual report to shareholders Nov 8, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
ARS Annual report to shareholders Jun 2, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2022 Dec 31, 2021
10-K/A Amended annual report May 14, 2021 Dec 31, 2020
10-K/A Amended annual report Mar 26, 2021 Dec 31, 2020
10-K Annual report Mar 23, 2021 Dec 31, 2020
10-K Annual report Mar 26, 2020 Dec 31, 2019
10-K/A Amended annual report Jul 24, 2019 Dec 31, 2018
10-K Annual report Feb 19, 2019 Dec 31, 2018
10-K Annual report Mar 13, 2018 Dec 31, 2017
10-K Annual report Mar 10, 2017 Dec 31, 2016
10-K Annual report Mar 10, 2016 Dec 31, 2015
10-K Annual report Jun 10, 2015 Mar 31, 2015
10-K/A Amended annual report Jul 23, 2014 Mar 31, 2014
10-K Annual report Jun 30, 2014 Mar 31, 2014

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PULM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Framingham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1574235
Former names
Ruthigen, Inc. (until Jun 16, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.